Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FABT5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,861
Award facts
- Contract value 100% obligated
- $56,861.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes with a ceiling value of $56,861.13 under a firm fixed price contract. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award made under an existing contract vehicle, reflecting the contractor's established relationship with the federal government for pharmaceutical supply.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies critical medications and medical commodities to the Defense Health Agency and other federal healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under the contractor's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare programs. Dupixent is indicated for the treatment of moderate-to-severe atopic dermatitis and other inflammatory conditions, making this procurement consistent with the contractor's extensive portfolio of specialty and brand-name pharmaceutical products supporting federal medical needs.
Quick answers
Who was awarded contract SPE2DB26FABT5?
SPE2DB26FABT5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FABT5 worth?
The government has obligated $56,861 on SPE2DB26FABT5.
Is contract SPE2DB26FABT5 an order under another contract?
Yes. SPE2DB26FABT5 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABT5 competed?
The extent of competition for SPE2DB26FABT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award